Pharma, Biotech and Generics Industry News | The Pharmaletter
WEBSep 17, 2024 — Pharma, Biotech and Generics Industry News | The Pharmaletter. Pharmaceutical. Greek pharma report lays bare industry’s impact. The Foundation for Economic and Industrial Research and Greek pharma trade group the Hellenic Association of Pharmaceutical Companies have presented two studies reflecting the industry’s importance.23 September 2024.
Pharma News and Insights Podcast | The Pharmaletter
WEBJul 17, 2023 — The Pharma Letter Podcast — Episode 22 — A new way to innovate, from Flagship Pioneering. Flagship Pioneering has had an outsized impact on the sector, launching a spate of successful biotechs, including Moderna Therapeutics. Now, with Pioneering Medicines, the group hopes to shake things up again. 20 April 2023.
Subscribe to The Pharma Letter | The Pharmaletter
WEBThe Pharma Letter. 39-43 Putney High Street, Putney London, SW15 1SP United Kingdom
Pharmaceutical Industry News | The Pharmaletter
WEBSep 5, 2024 — FDA snubs Vanda Pharma's NDA for tradipitant in gastroparesis. Vanda Pharmaceuticals’ shares were down more than 10% at $4.45 pre-market today, as the) company provided an unfavorable update on its tradipitant development program. 19 September 2024.
Long Grove Pharma set to be a new leader in specialized generics
WEBApr 22, 2022 — Long Grove Pharma set to be a new leader in specialized generics. Illinois, USA-based Long Grove Pharmaceuticals, founded in 2019 by strategic health care investor Water Street Healthcare Partners, will begin shipping its first products in mid-2022. Dedicated to bringing high-demand, high-quality health …
Contact Us - The Pharma Letter
WEBSep 17, 2024 — The Pharma Letter. 39 to 43 Putney High Street. Putney. London. SW15 1SP. For trial and subscription enquiries please email [email protected]. For editorial enquiries, press releases and events please email [email protected]. For all other queries please email [email protected].
Russia’s leading insulin producer Geropharm eyes expansion in …
WEB26 July 2022. Geropharm, one of Russia’s largest drugmakers and a leading producer of insulin, is eyeing accelerating its foreign expansion as well as increasing its output by almost five-fold, according to recent statements by Petr Rodionov, the firm’s general director. Mr Rodionov said in an interview with the Russian Vedomosti business ...
Pharmaceutical Generics Industry News | The Pharmaletter
WEBMay 24, 2024 — Glenmark pays $25 million fine for generic price-fixing. Glenmark Pharmaceuticals has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug, the US Department of Justice announced. 5 September 2024.
ChemRar | Pharmaceutical - The Pharmaletter
WEBTogether with the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, ChemRar's work on Avifavir helped it to become the first favipiravir-based drug in the world approved for the treatment of COVID-19, according to the companies. The RDIF has a 50% stake in ChemRar, which celebrated its 30th anniversary in 2020.
Kolon TissueGene cleared to resume US Phase III trial for Invossa
WEBApr 14, 2020 — The trial had been suspended due to product identity concerns, the company noted, adding that the firm’s US unit, Kolon TissueGene, has begun activities to resume the Phase III trial and reinitiate enrollment later this year. The clinical exploration was halted last May after Invossa’s cell line was found to have been mislabeled as ...
Skip to content